Effect of stachydrine hydrochloride to the prostate hyperplasia model in mice

Study the effect of stachydrine hydrochloride to prostatic hyperplasia in mice which made of the urogenital sinus implantation. KM male mices were selected. The group was given the respective drugs for gavage, the group of BG and MG were given the distilled water which the same amount as the drugs group for 21 consecutive days. The level of DHT, ACP, Non PACP were measured in serum, the average wet weight of the prostate and prostate index were calculated, the expression of bFGF, EGF, IGF-I, TGF-β in prostate tissue were measured, the pathological changes of the prostate, kidney, thymus, spleen were observed by HE staining. Compared with MG, stachydrine hydrochloride high (SHH), medium (SHM) and low (SHL) group could reduced the level of DHT and PACP in serum significantly (P < 0.01); SHM and SHL could increased the express of TGF-β1 significantly (P < 0.05); SHH, SHM, SHL could reduced the express of EGF significantly (P < 0.01); SHM could reduced the express of IGF-Ⅰ significantly (P < 0.01); Compared with MG, SHH, SHM, SHL could reduced the pathological changes of prostate significantly (P < 0.01); FG could reduced the kidney pathological changes significantly (P < 0.01). Stachydrine hydrochloric had no significant effect on the kidney. Stachydrine hydrochloride had the effect of improve thymus, spleen pathological changes. Stachydrine hydrochloride has a good inhibition effect on prostatic hyperplasia model in mices.